Stem Cell Training and N-Biotek, Inc. have announced plans to launch a post-graduate studies program in stem cell and regenerative medicine, to be conducted in Seoul Korea in 2017.
MIAMI, JAN. 09, 2017—Stem Cell Training,Inc., a division of Global Stem Cells Group, Inc., and N-Biotek Inc have announced plans to launch a post graduate studies program in stem cell therapies and regenerative medicine in 2017.

The program will include Seven days of intensive, interactive training coursework with classroom instruction and laboratory practice through didactic lectures, hands-on practical experience in laboratory protocols and relevant lessons in regulatory practices. N-Biotek’s Chief Scientific Officer and Other leading Scientists will teach the coursework and perform laboratory instruction, accompanied by a series of guest lecturers from the Global Stem Cells Group faculty of scientists.

Attendees will receive hands-on training in techniques for a variety of laboratory processes, and gain insight into the inner workings of a cGMP laboratory and Korean FDA registered tissue bank. Regenerative medicine experts with more 15 years of experience in the field will train attendees and provide the necessary tools to implement regulatory and clinical guidelines in a cGMP laboratory setting.

The graduate course is to be four times in Seoul in March 2017.
Course details, objectives and instruction include:
● Laboratory Training
● Hands-On Training
● Plating Stem Cells
● Harvesting and Freezing stem cells (perform counts and flow)
● Gram Stain
● Trypan
● Mycoplasma
● Gowning to enter cleanroom
● Flow Cytometry
● Endotoxin
● Sterility
● Environmental monitoring
● Calibration and PM
Didactic Lectures will include:
● Stem Cell Biology
● Cell Culture
● Trypsin
● Plating
● Flow Cytometry
● Gram Stain
● Trypan
● Potency (differentiation)
● Cryopreservation
● Quality control: endotoxin, sterility, mycoplasma
● Gowning to enter cleanroom
● Cleanroom Maintenance
● Environmental monitoring
Laboratory Protocols
For additional information, visit the Stem Cell Training, Inc. website, email info(at)stemcelltraining(dot)net, or call 305-560-5337

About Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.

Global Stem Cells Groups corporate mission is to make the promise of Regenerative medicine a reality for patients around the world. With each of GSCGs six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.

Global Stem Cells Group is a publicly traded company operating under the symbol MSSV.

About Stem Cell Training, Inc.:
Stem Cell Training, Inc. is a multi-disciplinary company offering coursework and training in 35 cities worldwide. Coursework offered focuses on minimally invasive techniques for harvesting stem cells from adipose tissue, bone marrow and platelet-rich plasma. By equipping physicians with these techniques, the goal is to enable them to return to their practices, better able to apply these techniques in patient treatments.

The company’s training courses are designed to make the best use of stem cell technology available to treat various diseases in a manner that is accessible to everyone. Stem Cell Training, Inc.’s mission is to introduce the promising world of cellular medicine to everyone who can benefit from its application, and to provide high quality, effective and efficient training that complies with the highest medical standards to physicians worldwide.

Previous Post
IFATS Recommendations for FDA Regulation of Human Cells, Tissues, and Cellular and Tissue-Based Products
Next Post

Latest posts